[HTML][HTML] Deprescribing in a family health team: a study of chronic proton pump inhibitor use
K Walsh, D Kwan, P Marr, C Papoushek… - Journal of primary …, 2016 - CSIRO Publishing
BACKGROUND Proton pump inhibitors (PPIs) are often used inappropriately, without an
indication, or for longer durations than recommended. Few tools exist to guide reassessment of …
indication, or for longer durations than recommended. Few tools exist to guide reassessment of …
Implementation of a self‐administered questionnaire to identify patients at risk for medication‐related problems in a family health center
…, D Jorgenson, D Kwan, C Papoushek - … : The Journal of …, 2006 - Wiley Online Library
Study Objective. To determine if a self‐administered questionnaire can improve the
identification of patients at risk for medication‐related problems (MRPs) compared with usual …
identification of patients at risk for medication‐related problems (MRPs) compared with usual …
The “glitazones”: rosiglitazone and pioglitazone
C Papoushek - Journal of Obstetrics and Gynaecology Canada, 2003 - Elsevier
Rosiglitazone and pioglitazone are two new additions to the therapeutic options for the treatment
of type 2 diabetes mellitus. These agents differ from our current therapies in their mode …
of type 2 diabetes mellitus. These agents differ from our current therapies in their mode …
[HTML][HTML] Canadian Stroke Best Practice Recommendations: acetylsalicylic acid for prevention of vascular events
This set of recommendations is intended to provide guidance for the use of ASA for primary
prevention of vascular events. Additionally, the guideline comments on secondary stroke …
prevention of vascular events. Additionally, the guideline comments on secondary stroke …
[PDF][PDF] Exploring professional culture in the context of family health team interprofessional collaboration
R Walji, C Papoushek, Z Austin - 2011 - academia.edu
BACKGROUND While family health teams (FHTs) seek to deliver collaborative patient-centered
care, the barriers that can arise due to a practitioner’s professional culture pose a …
care, the barriers that can arise due to a practitioner’s professional culture pose a …
Designing a novel continuing education program for pharmacists: Lessons learned
Rapid changes in health care and the evolving role of the pharmacist, as shown by the recent
expanding scope of practice changes in several Canadian jurisdictions, have created a …
expanding scope of practice changes in several Canadian jurisdictions, have created a …
Evaluation of a community pharmacy–based screening questionnaire to identify patients at risk for drug therapy problems
…, K Mansell, D Kwan, C Papoushek… - … : The Journal of …, 2015 - Wiley Online Library
Study Objective To determine if a short screening questionnaire can identify patients at risk
for drug therapy problems ( DTP s) in a community pharmacy setting. Design Self‐…
for drug therapy problems ( DTP s) in a community pharmacy setting. Design Self‐…
[HTML][HTML] Physician and nurse practitioner perspectives of a modified Routine Opioid Outcome Monitoring (ROOM) Tool
C Lam, P Marr, K Leblanc, C Papoushek… - Journal of Primary …, 2023 - CSIRO Publishing
Introduction The Routine Opioid Outcome Monitoring (ROOM) Tool was developed for use
in community pharmacies in Australia. It facilitates pharmacists’ screening and brief …
in community pharmacies in Australia. It facilitates pharmacists’ screening and brief …
[PDF][PDF] managing anticoagulation. Comparison of results at three primary care centres.
REG Upshur, C Papoushek, D Macdonald… - Canadian family …, 2003 - cfp.ca
METHOD Patients receiving warfarin for more than 6 months were recruited from three sites:
193 from the Family Practice Units at Sunnybrook and Women’s College Health Sciences …
193 from the Family Practice Units at Sunnybrook and Women’s College Health Sciences …
Anticoagulation management: an interdisciplinary curriculum for family medicine residents
…, P Marr, D Toubassi, D Kwan, C Papoushek - Canadian Medical …, 2023 - erudit.org
Implication Statement Anticoagulants are high-risk medications with the potential to cause
significant patient harm if inappropriately managed. Medical trainees and practicing …
significant patient harm if inappropriately managed. Medical trainees and practicing …